Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More
-
POC Lipid Testing
... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of the ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth in ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Molecular Diagnostics
... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end of ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Disease Diagnostics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$53.0 Billion by the end of the analysis ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end of the ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Genetic Disorders, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$3.0 Billion by the end of the analysis ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Bacterial Enteric Disease, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end ... Read More
-
Histology and Cytology
... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More
-
Immunohematology Analyzers and Reagents
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the end ... Read More
-
In-Vitro Diagnostics (IVD) Packaging
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$4.6 ... Read More
-
Blood Culture Tests
... at a CAGR of 6.0% over the analysis period 2024-2030. Instrument, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Cardiac POC Testing Devices
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More
-
Clostridium Diagnostics
... CAGR of 14.2% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$9.1 Billion by the end of the analysis period. ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by the ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
Clinical Diagnostics Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More
-
Metabolic Testing Solutions
... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More
-
Digital Pathology Systems
... at a CAGR of 12.8% over the analysis period 2024-2030. Device, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$1.1 Billion by the end of the ... Read More
Research Assistance
